zzlangerhans’ Activity

Mon Oct 27

CAPS Underperform Pitch

zzlangerhans wrote about Vanda Pharmaceuticals, Inc. (VNDA) . 10:42 PM

VNDA Underperform

Looks like this is my first CAPS pitch in over a month. Fitting that it should be yet another kick to the bruised rump of Vanda. Why is this stock fascinating? Because it's one of the flagship positions of the Baker Bros hedge fund, who still possess [more]

Caps Pick

zzlangerhans made a pick in CAPS. 2:32 PM

Vanda Pharmaceuticals, Inc. (VNDA) will Underperform the S&P 500

CAPS Underperform Pitch Reply

zzlangerhans commented on zzlangerhans's pitch for PTIE. 11:48 AM

Took a while though. I wonder how many traders successfully navigated the price double before the Sword of Damocles dropped.

Wed Sep 24

CAPS Outperform Pitch Reply

zzlangerhans commented on zzlangerhans's pitch for RGDO. 7:53 PM

Up to 30K shares now cost basis 1.71.

Sun Sep 21

CAPS Outperform Pitch

zzlangerhans wrote about Regado BioSciences, Inc. (RGDO) . 2:59 AM

RGDO Outperform

Quite often after profiting on a trade where the favorable outcome had seemed almost inevitable, I ask myself why I hadn't gone bigger and doubled or tripled my profits.The answer, of course, is the existence of stocks like Regado which appear on the [more]

Sat Sep 20

CAPS Outperform Pitch

zzlangerhans wrote about MannKind Corp (MNKD) . 2:52 AM

MNKD Outperform

It's a little sad that the five year price chart on YahooFinance doesn't take me back all the way to when I started covering Mannkind. I always thought I'd be a stock market billionaire before I got to this point. Perhaps I'm not because I never put [more]

Wed Sep 17

CAPS Underperform Pitch

zzlangerhans wrote about AVANIR PHARMACEUTICALS (AVNR) . 9:16 AM

AVNR Underperform

Avanir's share price doubled on Monday morning after the pre-market announcement of positive topline results from a placebo-controlled phase II trial of Nuedexta (AVP-923) for Alzheimer's agitation. I red thumbed it reflexively when the stock seemed [more]

Tue Sep 16

Caps Pick

zzlangerhans made a pick in CAPS. 1:35 PM

Regado BioSciences, Inc. (RGDO) will Outperform the S&P 500

CAPS Outperform Pitch

zzlangerhans wrote about AKEBIA THERAPEUTICS INC COM USD0.00001 (AKBA) . 11:22 AM

AKBA Outperform

I recently added Akebia to my database but it's rather difficult to find anything to get excited about. The platform is based on stimulation of the hypoxia-inducible factor pathway through small molecule inhibitors of HIF prolyl hydroxylase, the [more]

Mon Sep 15

Caps Pick

zzlangerhans made a pick in CAPS. 12:43 PM

AKEBIA THERAPEUTICS INC COM USD0.00001 (AKBA) will Outperform the S&P 500

Caps Pick

zzlangerhans made a pick in CAPS. 10:14 AM

AVANIR PHARMACEUTICALS (AVNR) will Underperform the S&P 500

Fri Sep 12

CAPS Outperform Pitch Reply

zzlangerhans commented on zzlangerhans's pitch for AMRN. 2:45 PM

Already out at 1.46 for a profit of $300. Couldn't resist the urge to take some profits on this trader killer.

CAPS Outperform Pitch

zzlangerhans wrote about Amarin Corp plc (ADR) (AMRN) . 10:37 AM

AMRN Outperform

The "revocation of the revocation" trade in Amarin never made much sense to me. The FDA revoked the ANCHOR SPA for a clear reason - to allow a more orderly rejection of Vascepa for the ANCHOR indication, with a reduced risk of legal [more]

Caps Pick

zzlangerhans made a pick in CAPS. 9:35 AM

Amarin Corp plc (ADR) (AMRN) will Outperform the S&P 500

Wed Sep 10

CAPS Underperform Pitch Reply

zzlangerhans commented on TMFBiologyFool's pitch for ARNA. 10:00 PM

The 3 word pitch wins. The Doctor lost the patient.

CAPS Outperform Pitch Reply

zzlangerhans commented on zzlangerhans's pitch for MNOV. 3:09 PM

And sold at 2.82 six months later for profit of $3150. Who knows - this could be the next POS to be a ten bagger but I hate holding winning positions I don't like just on the basis of momentum.

Tue Sep 9

CAPS Underperform Pitch

zzlangerhans wrote about Chimerix (CMRX) . 6:50 PM

CMRX Underperform

Chimerix is ripping of late and I smell a rat. The stock was ailing in May even after the company solved their compassionate use PR nightmare, and management found the exact bottom of the stock to price a huge dilutive financing of 112M. Since then [more]

Caps Pick

zzlangerhans made a pick in CAPS. 2:59 PM

MannKind Corp (MNKD) will Outperform the S&P 500

Caps Pick

zzlangerhans made a pick in CAPS. 10:27 AM

Chimerix (CMRX) will Underperform the S&P 500

Mon Sep 8

CAPS Underperform Pitch Reply

zzlangerhans commented on zzlangerhans's pitch for KERX. 2:29 PM

Covered at 15.19 for $880 profit in six hours (market time). Still in proof of concept mode when it comes to shorting.

Show More Activity ...

CAPS Stats & Trivia

CAPS Player Rating 99.80
Player Rank 153 out of 75056
Score 6213.38
Score Change Today +105.41
Accuracy 82.19%
Active Picks 154
Total Picks 1945
Best Pick MDVN (+1181.16)
Worst Pick PCYC (-2886.09)
Average Score per Pick 3.19
Charms Earned 15
Highest Rated Favorite usubanas
Go to zzlangerhans’ CAPS page

Boards Stats & Trivia

Board Posts 0
Recs Received 0
People who have rec'd these posts 0
Recs to Posts Ratio (last 30 days) N/A
Threads Started 0
Threads Started Percentage 0.00 %
Most Frequent Board N/A
Very First Post N/A
Percentage of Posts Rec'd 100.00 %
Show zzlangerhans’ 10 Latest Posts